Kamada (KMDA) Tax Rate (2012 - 2026)
Kamada's (KMDA) quarterly Tax Rate came in at 9.1% in Q2 2026, down 3731.0% on a YoY basis from 0.25% in Q2 2025, and up 61.04% quarter-over-quarter from 23.35% in Q1 2026.
Powered by 
Analysis
Kamada (KMDA) Tax Rate (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Tax Rate for 13 consecutive years, with 9.1% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate fell 3731.0% year-over-year to 9.1%; the trailing twelve-month figure through Jun 2026 stood at 16.6% (down 1787.0% YoY), and the FY2025 full-year result was 13.93%, down 2239.0% from the prior year.
- Tax Rate climbed to 9.1% in Q2 2026 per KMDA's latest filing, from 23.35% in the prior quarter.
- Across five years, Tax Rate topped out at 54.86% in Q4 2024 and bottomed at 40.06% in Q1 2025.
- Historically, Tax Rate has averaged 1.72% across 5 years, with a median of 1.06% in 2023.
- The sharpest annual moves came in 2024 and 2025: Tax Rate jumped 5418 bps in 2024, then sank 7962 bps in 2025.
- Over 5 years, Tax Rate stood at 0.07% in 2022, then jumped by 897 bps to 0.68% in 2023, then soared by 8006 bps to 54.86% in 2024, then plunged by 145 bps to 24.76% in 2025, then surged by 63 bps to 9.1% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 9.1%, 23.35%, and 24.76% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn | 1.34% |
| 10 | Kamada | 473.28 Mn | 403.14 Mn | 22.47 Mn | -9.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.10% |
| Mar 31, 2026 | -23.35% |
| Dec 31, 2025 | -24.76% |
| Sep 30, 2025 | -16.82% |
| Jun 30, 2025 | 28.21% |
| Mar 31, 2025 | -40.06% |
| Dec 31, 2024 | 54.86% |
| Sep 30, 2024 | -2.13% |
| Jun 30, 2024 | -1.40% |
| Mar 31, 2024 | -3.03% |
| Dec 31, 2023 | 0.68% |
| Sep 30, 2023 | 2.21% |
| Jun 30, 2023 | 4.88% |
| Mar 31, 2023 | -0.72% |
| Dec 31, 2022 | 0.07% |
| Sep 30, 2022 | 2.02% |
| Jun 30, 2022 | -0.23% |
| Mar 31, 2022 | -2.29% |
| Dec 31, 2020 | 14.71% |
| Sep 30, 2020 | 4.84% |